Neopath (NPTH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neopath (NPTH)

NPTH 0.000600

0.0%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joseph Ziebarth who wrote (166)	3/24/1999 4:24:00 PM
From: Richard Cohen	Read Replies (1) of 178

Thanx for the input. I've bought some shares over the past few days.Assuming the co. doesn't disappear, the downside risk is minimal at $4/share considering this was a $16 stock earlier in the year.I don't know much about the competition but if Prudential is choosing their product, that's a good thing. This partnership announced yesterday also seems to make the co. viable. This co. is a risk, but at this point I'll take it. If the demand is as great as you say, someone should pick up on it sooner or later.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next